Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP367208.RAeaclxfp8pN-NLhhYP4jDNxco0wJ5c7qt951aUxdgf3s130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367208.RAeaclxfp8pN-NLhhYP4jDNxco0wJ5c7qt951aUxdgf3s130_provenance.
• NP775210.RADQyjm6vYDaGNmys-NyLIaNcujSVjsDy5teVF55vb3y4130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775210.RADQyjm6vYDaGNmys-NyLIaNcujSVjsDy5teVF55vb3y4130_provenance.
• NP933541.RAC_BPYxsbLvtSW1IYVzdCBhlMq3FWkEvy-0-MzQU4oTo130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933541.RAC_BPYxsbLvtSW1IYVzdCBhlMq3FWkEvy-0-MzQU4oTo130_provenance.
• NP496232.RAfmangsjD12Q2EbsfHLlOeaucWEKpNcrpK2iibnxoD4Q130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496232.RAfmangsjD12Q2EbsfHLlOeaucWEKpNcrpK2iibnxoD4Q130_provenance.
• NP856067.RAejpycx-3li_osb-E18SQntWoyVVL9EbiJZmDSwCGorI130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856067.RAejpycx-3li_osb-E18SQntWoyVVL9EbiJZmDSwCGorI130_provenance.
• NP445852.RAFalJqm-qHoEfzKbKgFfMsE8rqo9_KUicIXWL2BidBjY130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445852.RAFalJqm-qHoEfzKbKgFfMsE8rqo9_KUicIXWL2BidBjY130_provenance.
• NP878664.RAwqdt2aCj8QrAXu9nF3Ib56cG-Ms211JOuYO4N0IeIYk130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878664.RAwqdt2aCj8QrAXu9nF3Ib56cG-Ms211JOuYO4N0IeIYk130_provenance.
• NP561804.RAOoVJPjyY6uQqJCWzJnQM8i-R8WcVCI7mzmJFMtq8-HQ130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561804.RAOoVJPjyY6uQqJCWzJnQM8i-R8WcVCI7mzmJFMtq8-HQ130_provenance.
• NP656127.RAOhaO0jSXJHdwPmxopAaPk3DtxcBqNhti9LooWTFvKkY130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656127.RAOhaO0jSXJHdwPmxopAaPk3DtxcBqNhti9LooWTFvKkY130_provenance.
• NP779619.RAGVjp49dxe32re1nryGstX6SDYBf_9txCKwWhbWxgw84130_assertion description "[Moreover, the palmitoyl acyl transferase (PAT) inhibitor blocks the ability of ERbeta-E2 complex to activate p38 impairing the receptor-dependent activation of downstream proapoptotic cascade (i.e., caspase-3 activation and poly(ADP-ribose)polymerase (PARP) cleavage).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779619.RAGVjp49dxe32re1nryGstX6SDYBf_9txCKwWhbWxgw84130_provenance.